Skip to content
Search

Latest Stories

Peak Pharmacy closing its Malvern store in late February

Peak Pharmacy closing its Malvern store in late February

The group cited economic pressures as reason for their decision to close its outlet in Church Street

After Boots’ closure in last March, Peak Pharmacy has now confirmed it plan to close its store in Great Malvern.


The Peak Pharmacy in Church Street, which is the only chemist currently running in the area, will be closed permanently from February 29, 2024, Malvern Gazette reported.

West Worcestershire MP Harriett Baldwin told the publication that Peak Pharmacy has written to him confirming the news and explaining the decision.

He is disappointed that “this is the second pharmacy to exit Church Street in a year” which would affect people who have been rely on the chemist shop.

According to the MP, efforts are being made to find a replacement, and he has reached out to the body responsible for managing pharmacy provision in the area for an alternative plan.

Councillor Beverley Nielsen, Malvern Hills District Council economic development and tourism portfolio holder, feels that the closure of Peak Pharmacy “is a real loss to Great Malvern” as he is worried that they won’t have a local chemist based in the town.

He informed Malvern Gazette that MHDC’s economic development team has been trying hard to retain one pharmacy as it is an important service for the residents.

They have also contacted Peak Pharmacy to see if the retailer might be ready to sell on their licence, but the company has declined their offer.

At the same time, the team is reaching out to other chemist groups who might be interested in operating in Malvern, but there are no guarantees at this stage, the Councillor added.

Meanwhile, Matt Webster, Peak Pharmacy head of retail operations, stated that they made this decision with “a heavy heart,” and that they’re not immune to the economic pressures facing the community pharmacy sector at the moment.

However, he assured that their three other outlets in Worcester Road in Malvern Link, Pickersleigh Road and Maple Road will continue to support their patients, and give “fantastic levels of pharmacy care."

The picture shown above is a representational image sourced from Peak Pharmacy Website. 

More For You

RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less